SilvaJ, dos SantosS. Sepsis in AIDS Patients: Clinical, etiological and inflammatory characteristics. J Int AIDS Soc, 2013; 16:17344.
2.
KwizeraA, NabukenyaM, PeterA, et al.Clinical characteristics and short-term outcomes of HIV patients admitted to an african intensive care unit. Crit Care Res Pract, 2016; 2016:Article ID 2610873.
3.
MoreiraJ, AmancioR, CoelhoL, et al.Interactions between HIV infection and sepsis among critically ill patients: A systemic review. Clin Res HIV AIDS, 2015; 2:1021–1027.
4.
MoreiraJ. The burden of sepsis in critically ill human immunodeficiency virus-infected patients—A brief review. Braz J Infect Dis, 2015; 19:77–81.
5.
MorquinD, MoingVL, MuraT, et al.Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: Impact of antiretroviral therapy and immunological status. Ann Intensive Care, 2012; 2:25.
6.
CasalinoE, WolffM, RavaudP, et al.Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an Intensive care unit. AIDS, 2004; 18:1429–1433.
7.
MeybeckA, LecomteL, ValetteM, et al.Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study. AIDS Res Ther, 2012; 9:27.
8.
VenturasJ. Initiation of antiretrovirals in critically ill patients. South Afr J Anaesth Analg, 2011; 17:132–135.
9.
WadaNI, JacobsonLP, MargolickJB, et al.The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS, 2015; 29:463–471.
10.
KastenKR, TschopJ, AdediranSG, et al.T cells are potent early mediators of the host response to sepsis. Shock, 2010; 34:327–336.
11.
HuesgenE, DeSearKE, EgelandEF, et al.A HAART-breaking review of alternative antiretroviral administration: Practical considerations with crushing and enteral tube scenarios. Pharmacotherapy, 2016; 36:1145–1165.
12.
TakeshiM, TakeshiN, KatsujiT, et al.Substantially higher and earlier occurrence of anti-tuberculosis drug-related adverse reactions in HIV coinfected tuberculosis patients: A matched-cohort study. AIDS Patient Care STDS, 2017; 31:455–462.
